JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 90 filers reported holding JOUNCE THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.52 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,406,000 | +8.7% | 168,424 | -3.3% | 0.03% | +16.0% |
| Q3 2021 | $1,294,000 | -46.8% | 174,175 | -51.3% | 0.02% | -44.4% |
| Q2 2021 | $2,433,000 | -30.1% | 357,817 | +5.6% | 0.04% | -39.2% |
| Q1 2021 | $3,481,000 | +24.3% | 338,969 | -15.3% | 0.07% | +17.5% |
| Q4 2020 | $2,800,000 | -27.2% | 400,013 | -15.2% | 0.06% | -51.9% |
| Q3 2020 | $3,848,000 | +8.1% | 471,622 | -8.6% | 0.13% | +1.6% |
| Q2 2020 | $3,559,000 | +183.6% | 515,748 | +95.3% | 0.13% | +89.7% |
| Q1 2020 | $1,255,000 | +17.5% | 264,139 | +116.0% | 0.07% | +38.8% |
| Q4 2019 | $1,068,000 | +161.1% | 122,282 | -0.5% | 0.05% | +113.0% |
| Q3 2019 | $409,000 | -28.9% | 122,912 | +5.9% | 0.02% | -17.9% |
| Q2 2019 | $575,000 | -26.1% | 116,080 | -7.5% | 0.03% | -33.3% |
| Q1 2019 | $778,000 | +75.6% | 125,533 | -4.5% | 0.04% | +35.5% |
| Q4 2018 | $443,000 | -49.6% | 131,393 | -2.9% | 0.03% | -35.4% |
| Q3 2018 | $879,000 | -12.8% | 135,280 | +2.8% | 0.05% | -21.3% |
| Q2 2018 | $1,008,000 | -62.6% | 131,592 | +9.1% | 0.06% | -68.7% |
| Q1 2018 | $2,695,000 | +79.1% | 120,585 | +2.1% | 0.20% | +65.3% |
| Q4 2017 | $1,505,000 | – | 118,060 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 10,230,349 | $228,648,000 | 42.85% |
| Pharmstandard International S.A. | 662,063 | $14,797,000 | 37.17% |
| TRV GP III, LLC | 3,048,780 | $68,140,000 | 24.53% |
| Omega Fund Management, LLC | 529,965 | $11,845,000 | 11.64% |
| Casdin Capital, LLC | 635,000 | $14,192,000 | 2.50% |
| Virtus ETF Advisers LLC | 58,867 | $1,316,000 | 1.14% |
| Redmile Group, LLC | 1,182,393 | $26,426,000 | 1.02% |
| PFM Health Sciences, LP | 1,923,651 | $42,994,000 | 0.87% |
| Elephas Investment Management Ltd | 154,400 | $3,451,000 | 0.63% |
| Ghost Tree Capital, LLC | 125,092 | $2,796,000 | 0.57% |